2020 American Transplant Congress
Efficacy of Single-Strength Trimethoprim-Sulfamethoxazole Thrice Weekly for Pneumocysitis Jirovecii Pneumonia Prophylaxis Post Liver Transplantation
Infectious Diseases and Geographic Medicine, Stanford University, Stanford, CA
*Purpose: Current guidelines recommend Pneumocystis jirovecii pneumonia (PJP) prophylaxis for at least 6-12 months after liver transplant (LTx) with preferably Trimethoprim-sulfamethoxazole (TMP-SMX) at a daily…2020 American Transplant Congress
A Comparative Analysis of Mucormycosis in Solid Organ Transplant Recipients and Other Immunosuppressed Hosts Including Patients with Uncontrolled Diabetes
*Purpose: Mucormycosis is a rare disease that is associated with a high morbidity and mortality. It usually affects those with uncontrolled diabetes mellitus (DM) and…2020 American Transplant Congress
Rare Genetic Mutation Triggering Acute Liver Failure in a Toddler Needing a Liver Transplant
1Cleveland Clinic, Cleveland, OH, 2Akron Children's Hospital, Akron, OH
*Purpose: The AIRE gene plays an important role in immune tolerance by driving negative selection of self-recognizing T-cells. Mutations in this gene are responsible for…2020 American Transplant Congress
The Application of Electron Microscope Examination in Evaluation of Donor Liver Quality in Liver Transplantation
*Purpose: Liver transplantation (LT) is considered as the only curable treatment for patients with end stage liver diseases. Post-operative complications include early allograft dysfunction (EAD),…2020 American Transplant Congress
Ex-Vivo Repair of Complex Hilar Renal Artery Aneurysms and Auto-Transplantation of Solidary Kidney
*Purpose: We present a case of ex-vivo repair of complex renal hilar saccular aneurysm followed by auto-transplantation of the solitary kidney.*Methods: The patient was a…2020 American Transplant Congress
Bortezomib Exhibits Therapeutic Implication in Renal Interstitial Fibrosis after Kidney Transplantation by Inhibiting Akt-mTOR-P70S6K-Smurf2 Pathway and Stabilizing IκBα Protein
Jiangsu Province Hospital, Nanjing, China
*Purpose: Allograft interstitial fibrosis and fibrogenesis significantly exacerbate the progression of chronic allograft disease (CAD) and are essential therapeutic targets. Epithelial‐mesenchymal transition (EMT) is recognized…2020 American Transplant Congress
Multi-Organ Procurement Organization Review of the Impact of Reactive Anti-HCV and HCV NAT Results
LifeShare Transplant Donor Services of Oklahoma, Oklahoma City, OK
*Purpose: Previously a single organ procurement organization (OPO) reviewed data from a 15 month cohort (1/1/2016 to 3/31/17) and concluded that donors who tested positive…2020 American Transplant Congress
Access to Direct Acting Antiviral Therapy for Recipients of Solid Organs from Hepatitis C Viremic Donors
Vanderbilt University Medical Center, Nashville, TN
*Purpose: Emerging data supports transplantation of organs from hepatitis C-positive (HCV) donors to expand the donor pool, but access to direct acting antivirals (DAAs) to…2020 American Transplant Congress
Incidence of Urinary Tract Infections in Kidney Transplant Recipients Receiving Alternate Antimicrobial Prophylaxis Regimens
1UCSF Health, San Francisco, CA, 2UC Davis, Davis, CA
*Purpose: Urinary tract infections (UTI) occur frequently in renal transplant (RT) recipients. Antimicrobial prophylaxis may help prevent UTI early post RT. Trimethoprim/sulfamethoxazole (TMP/SMX) is the…2020 American Transplant Congress
Donor Derived Parvovirus B19 Infection
*Purpose: At present,donor derived parvovirus B19 infections are rarely reported. Thus, the incidence of donor derived parvovirus B19 infections in solid organ transplant recipients is…
- « Previous Page
- 1
- …
- 427
- 428
- 429
- 430
- 431
- …
- 1683
- Next Page »